Clinical Trials in San Antonio

Showing 3141-3160 of 7,028 trials

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

NCT04592484

This is a first-in-human, Phase 1/2 open-label, multicenter, dose escalation, safety, pharmacodynamic, and PK study of CDK-002 in subjects with advanced/metastatic, recurrent, injectable solid tumors, whose disease has progressed despite receiving standard of care treatment. CDK 002 will be administered intratumorally (IT). Part A will enroll subjects with advanced/metastatic, recurrent, injectable solid tumors with emphasis on head and neck squamous cell cancer (HNSCC), triple negative breast cancer (TNBC), anaplastic thyroid carcinoma (ATC) and cutaneous squamous cell carcinoma (cSCC).

Advanced Solid Tumor

Codiak BioSciences27 participantsStarted Sep 2020

Scottsdale, Arizona, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664

The purpose of this research is to understand if the study drug, also called sargramostim or Leukine®, can help prevent the worsening of COVID-19 when the study drug is inhaled. This study will also help researchers understand if inhaled sargramostim can help prevent visits to the emergency room or hospitalization, or death.

Covid19SARS-CoV Infection

Partner Therapeutics, Inc.600 participantsStarted Apr 2021

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Canoga Park, California, United States +34 more locations

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Sargramostim Use in COVID-19 to Recover Patient Health

Find Trials by Condition in San Antonio

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Validation of a Salivary miRNA Diagnostic Test for ASD

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Shape Up! Kids Study

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

Rectal Microbicide Acceptability, Tolerability and Adherence

Neuro RX Gamma - Pivotal Phase

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment